bar3-02.png

MISSION STATEMENT

Through international partnerships, Terasaki Innovation Center, Inc. (TIC) will facilitate discovery and development of new pathways and tools needed to diagnose and manage allograft rejection. 

OUR PURPOSE

Driven by the legacy of Dr. Paul Terasaki and his vision for improving the lives of transplant patients worldwide, Terasaki Innovation Center, Inc. (TIC) will continue his quest for discoveries and innovations that will lead to a better understanding of the mechanism of allograft rejection. The overall goal of Terasaki Innovation Center, Inc. (TIC) is to support transplant clinicians and their patients via global collaborations.

Directors & Officers

Ricardo Ordoñez
President


Former Sr. Director of Marketing
& Customer Experience 

One Lambda, A Thermo Fisher Scientific Brand 

Los Angeles, California

Jar How Lee, Ph.D

Chief Scientific Officer
Treasurer/Board Member

 

Former Chief Scientific Officer 

One Lambda, A Thermo Fisher Scientific Brand 

Los Angeles, California

Mayra Lopez-Cepero, Ph.D. 
Secretary

Senior Vice President and Director
Transplant Immunology Lab
LifeLink Foundation
Tampa, Florida 

Peter Nickerson, MD
Board Member

 

Vice-Dean (Research) and Distinguished Professor

Medical Director, Transplant Manitoba University of Manitoba

Winnipeg, Canada

Robert Bray, Ph.D
Board Member


Co-Director, Histocompatibility & Molecular Immunogenetics Laboratory 

Emory University Hospital 

Atlanta, Georgia

Cathi Murphey, Ph.D.
Board Member 


President/COO 

Southwest Immunodiagnostics 

San Antonio, Texas 

Mark Terasaki, Ph.D

Chairman of the Board 
 

Associate Professor

Department of Cell Biology

University of Connecticut Health Center

Farmington, Connecticut

Moving the legacy of a transplant pioneer forward!

Questions: info@tictx.org

Terasaki Innovation Center, Inc. is a registered 501(c)(3) nonprofit organization
© 2021 Terasaki Innovation Center. All Rights Reserved.

  • Twitter
  • Instagram